© Crown copyright 2005 Safeguarding public health Reform of s12(1) of the Medicines Act 1968 London 2007 Name: Richard Woodfield, MHRA Date: January 2007.

Slides:



Advertisements
Similar presentations
Pharmacology and the Nursing Process in LPN Practice
Advertisements

Accredited Supplier Communications Plan FY09-10 Q1 to Q4 May 2009, v2.0 Home Access Marketing & Stakeholder Engagement Team.
Written Ministerial Statement DEPARTMENT OF HEALTH Practitioners of acupuncture, herbal medicine and traditional Chinese medicine Wednesday 16 February.
JCAHO –A HIPAA Business Associate National HIPAA Summit
Copyright © 2003 Pearson Education, Inc. Slide 1 Computer Systems Organization & Architecture Chapters 8-12 John D. Carpinelli.
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 6 Author: Julia Richards and R. Scott Hawley.
Author: Julia Richards and R. Scott Hawley
What Can SAFEFOODERA do for EFSA? GEOFFREY PODGER Executive Director EFSA.
© fedict All rights reserved Legal aspects Belgian electronic identity card Samoera Jacobs – November 2008.
1 Balloting/Handling Negative Votes September 22 nd and 24 th, 2009 ASTM Virtual Training Session Christine DeJong Joe Koury.
Task Group Chairman and Technical Contact Responsibilities ASTM International Officers Training Workshop September 2012 Scott Orthey and Steve Mawn 1.
International Organization International Organization
UNITED NATIONS Shipment Details Report – January 2006.
RXQ Customer Enrollment Using a Registration Agent (RA) Process Flow Diagram (Move-In) Customer Supplier Customer authorizes Enrollment ( )
1 Assessing Health Needs Gilbert Burnham, MD, PhD Johns Hopkins University.
Regional Policy EUROPEAN COMMISSION 1 EGTC regulation EGTC regulation ESF and EGTC regulations Regulation of the European Parliament and of the Council.
The Managing Authority –Keystone of the Control System
WHO Good Distribution Practices for Pharmaceutical Products
Harmonized implementation of CDM Accreditation CDM-Accreditation Panel.
1 RA I Sub-Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Casablanca, Morocco, 20 – 22 December 2005 Status of observing programmes in RA I.
1 ITU Interconnection Workshop 17 August 2001 Role of the Regulator K S Wong Office of the Telecommunications Authority Hong Kong, China.
Foreign Air Operator Validation & Surveillance
State of New Jersey Department of Health and Senior Services Patient Safety Reporting System Module 2 – New Event Entry.
Custom Statutory Programs Chapter 3. Customary Statutory Programs and Titles 3-2 Objectives Add Local Statutory Programs Create Customer Application For.
1 Targeted Case Management (TCM) Changes Iowa Medicaid Enterprise October 14, 2008.
Targeted Assistance & Schoolwide Programs NCLB Technical Assistance Audio April 18, :30 PM April 19, :30 AM Alaska Department of Education.
Health and Safety Executive Health and Safety Executive CDM 2007 Training Package Session 2 - Clients Version: September 07.
Good Clinical Practice in Research Clinical Trial Regulations
Chapter 7 COORDINATION WITH HMDOs [ENTER FACILITATORS NAME AND CONTACT INFORMATION] Developed by Troutman Sanders LLP Developed for the Virginia Department.
40 Tips Leveraging the New APICS.org to the Benefit of Your Organization, Members, and Customers! 1.
Site Safety Plans PFN ME 35B.
Engagement in Human Research & Multi-Site Studies K. Lynn Cates, M.D. Assistant Chief Research & Development Officer Director, PRIDE May 30, 2012.
Regulatory Reform (Fire Safety) Order 2005 Fire Safety Order What is the Fire Safety Order? The order was made, under the Regulatory Reform Act 2001.
EMS Checklist (ISO model)
Effectively applying ISO9001:2000 clauses 6 and 7.
Human Capital Investment Programme Disability Activation Project (DACT) WELCOME Support Workshop Thursday 7 th February
EU Market Situation for Eggs and Poultry Management Committee 21 June 2012.
XML and Databases Exercise Session 3 (courtesy of Ghislain Fourny/ETH)
2014 National Patient Safety Goals
1 Regulation of Sponsors and Independent Financial Advisers Joint HKEx / SFC Press Conference 19 October 2004.
Reform of S12(1): Implications for Herbal & Traditional Medicine Practitioners Michael McIntyre Chair EHTPA.
1 RA III - Regional Training Seminar on CLIMAT&CLIMAT TEMP Reporting Buenos Aires, Argentina, 25 – 27 October 2006 Status of observing programmes in RA.
Basel-ICU-Journal Challenge18/20/ Basel-ICU-Journal Challenge8/20/2014.
1..
From POM to P From POM to P Wellard’s NHS training wellards.co.uk 2004.
Senior Manager – Research Finance & Programmes
© Safeguarding public health Expert Group on Innovation in the Regulation of Healthcare products Adaptive Licencing workshop at the Wellcome Trust October.
CONTROL VISION Set-up. Step 1 Step 2 Step 3 Step 5 Step 4.
1 Attributing the costs of health & social care Research & Development – Understanding AcoRD Trudi Simmons Senior Manager – Research Finance & Programmes.
An introduction to… INTRODUCTION FROM THE SEA Wendy Jackson NZ Ministry of Foreign Affairs and Trade 1.
The Herbal Medicines Advisory Committee (HMAC) Alison Denham FNIMH EHTPA Regulation Conference 12 May 2007.
LACPA ISA Presentation
Visual 3.1 Delegation of Authority & Management by Objectives Unit 3: Delegation of Authority & Management by Objectives.
Analyzing Genes and Genomes
Page 1 of 36 The Public Offering functionality in Posting allows users to submit requests for public offerings of Petroleum and Natural Gas(PNG) and Oil.
Care and support planning Care Act Outline of content  Introduction Introduction  Production of the plan Production of the plan  Planning for.
Essential Cell Biology
PSSA Preparation.
Essential Cell Biology
Immunobiology: The Immune System in Health & Disease Sixth Edition
Energy Generation in Mitochondria and Chlorplasts
Overview of the Rotterdam Convention.
12-CRS-0106 REVISED 8 FEB 2013 PRESENTS Payment Functionality.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Responding to Inspection Findings
Options for Regulation of Unregistered Health Practitioners Consultation Forum.
EU Council Directive on Traditional Herbal Medicinal Products Dr. Dairine Dempsey IRISH MEDICINES BOARD for IHTA AGM 23 rd April 2003.
THE ALLIED HEALTH PROFESSIONS COUNCIL OF SOUTH AFRICA (AHPCSA) MEDICINES AND RELATED SUBSTANCES ACT (101/1965) AMENDMENT BILL (B6-2014) PRESENTATION BY.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Regulatory Authority.
© Crown copyright 2007 Safeguarding public health Common Inspection Findings May 2008.
Presentation transcript:

© Crown copyright 2005 Safeguarding public health Reform of s12(1) of the Medicines Act 1968 London 2007 Name: Richard Woodfield, MHRA Date: January 2007

Slide 2 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Crown copyright 2005 The materials featured within these MHRA presentation notes and delegate pack are subject to Crown copyright protection for this event. Any other copy or use of Crown copyright materials featured in this presentation, in any form or medium, is subject to prior approval of the MHRA which has Delegated Authority from Her Majesty's Stationery Office (HMSO) to administer Crown copyright for MHRA originated material. Applications should be in writing, clearly stating the proposed use/reuse of the information, and should be sent to the MHRA at the following address: Conference and Education Function, 16 th Floor, MHRA, 1 Nine Elms Lane, London SW8 5NQ. Fax or You may not sell or resell any information reproduced to any third party without prior agreement. The permission to reproduce Crown copyright protected material does not extend to any material in this pack which is subject to a separate licence or is the copyright of a third party. Authorisation to reproduce such material must be obtained from the copyright holders concerned.

Slide 3 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 An informal consultation…. We are here: -to explain ideas about reform of regulation, and -to listen

Slide 4 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Summary 1. What can go wrong with herbal medicines? 2. Objective – and whats been done to meet it 3. What is s12(1) and who uses it? 4. Proposals for reform of s12(1) 5. What next?

Slide 5 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What can go wrong with herbal medicines?

Slide 6 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What can go wrong with herbal medicines - summary? Wrong plant Contamination Deliberate adulteration/substitution/addition Foreign matter Poor information Inaccurate diagnosis & inappropriate prescribing

Slide 7 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Wrong plant! Digitalis (Foxglove) substituted for plantain heart problems Podophyllum substituted for Gentian causes cancer Japanese Star Anise substituted for Chinese Star Anise causes convulsions

Slide 8 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Wrong plant! Aristolochia species Aristolochia fanchi root used instead of Stephania sp. Aristolochia manschuriensis stem used instead of Clematis sp. Aristolochic acids - nephrotoxic, genotoxic, carcinogenic Cause kidney failure and cancer Belgium -110 cases renal failure, 18 cancers UK cases Aristolochia Banning Order 2001

Slide 9 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Deliberate addition of potentially hazardous materials Heavy metals/ toxic elements in Ayurvedic/ TCM products Muhayogaraj Guggulu mercury, lead and arsenic Fufang luhuijiaonang 11.7% mercury (over 100,000 times levels permitted in a food)

Slide 10 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Deliberate addition of potentially hazardous materials Undeclared pharmaceutical substances e.g.fenfluramine, nitrosofenfluramine, glibenclamide, corticosteroids, sidenafil, methyl phenidate, ephedrine Shubao Slimming Capsules nitrosofenfluramine associated with UK case of irreversible liver failure > 400 cases hepatotoxicity in Japan

Slide 11 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What can go wrong with practitioner supply of herbal medicines (i)? Practitioners tapping into international trade in low grade products and ingredients Lack of awareness of issues around side effects, interactions with other medicines, use in pregnancy, babies, children, elderly Failure to diagnose accurately; lack of awareness of limits of own competence Delaying effective treatment for serious conditions

Slide 12 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What can go wrong with practitioner supply of herbal medicines (ii)? Inadequate or cursory consultations Communication difficulties – eg practitioner unable to ask about existing medical conditions or medication already being taken Unhygienic premises – unsuitable for preparing medicines What is shelf life of ingredients; how are they stored? Failure to advise patient about safe usage No information on contents of product. Identification of adverse drug reactions can become impossible if you dont know what patient has taken Lack of accountability if patient wishes to make complaint

Slide 13 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What is on offer at the herbal clinic? Our herbal remedies are 100% safe Our medicines have no side effects Herbal remedies are safe because they are natural Chinese medicines will not interfere with any western medicines Treats heart disease Safer than western medicine Fights cancer

Slide 14 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Professional standards Dec 2006? What are the treatments? Herbal Remedies…treating a wide range of health problems, such as …. depression …. terminal illness, etc Clinic leaflet, Kent December 2006

Slide 15 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Objective and whats been done to meet it…

Slide 16 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 MHRA objective for herbal medicines Consumers to have access to wide range of herbal medicines; which are made to acceptable safety and quality standards; and which are accompanied by appropriate information about the safe use of the product

Slide 17 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Whats wrong with UK regime for unlicensed herbal medicines? Is the consumer assured of? Systematic safety standards Systematic quality standards Systematic information about safe use of product Competence and accountability of practitioner carrying out consultation and making up unlicensed medicines XxxxXxxx

Slide 18 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 The UK not alone in seeking to improve regulation…. In line with increased international demand, the safety, efficacy and quality of the products and practices used in TM/CAM have become important concerns for both health authorities and the public Therefore WHO Member States are seeking to establish policy frameworks and deciding in what ways these products and practices should be regulated….

Slide 19 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Overall UK herbal strategy: Reformed regulation of ….. OTC herbal medicines Statutory regulation of profession S12(1) Practitioner medicines

Slide 20 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Stool depends on strength of each leg…. OTC herbal medicines regulation S12(1) unlicensed herbal medicines prepared by practitioner Regulation of the profession

Slide 21 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 MHRA view: routes for safe supply of herbal (or any other) medicines…. Either The medicine should be an authorised/registered product made to assured standards; and with full, authorised information necessary for consumer to use product safety Or The medicine should be supplied by a practitioner; required to have recognised expertise; and subject to professional accountability

Slide 22 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Manufactured herbal medicines Moving to assured standards…. Until 2011 Some unlicensed herbal medicines where legally on UK market under s12(2) of the Medicines Act at April 2004 Herbal medicines with a marketing authorisation (PL) Coming soon! Herbal medicines with a traditional herbal registration (THR)

Slide 23 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 The first UK traditional herbal registration THR products made to assured standards of safety, quality and patient information Scheme launched Oct 2005 First THR granted Oct 2006 As at Jan applications received by MHRA -1 THR granted; others will follow -more applications in the pipeline

Slide 24 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What about regulating herbal practitioners and their use of unlicensed herbal medicines? Herbal Medicine Regulatory Working Group built on work of House of Lords Report on CAM (2000) and Governments response to it (2001) -recommended statutory regulation of herbal medicine profession -recommended reforms of s12(1) of Medicines Act 1968 DH and MHRA held linked consultations in 2004 Work continues: -Working group on statutory regulation of acupuncture, herbal medicine and traditional Chinese medicine practitioners -MHRA work on s12(1) reforms

Slide 25 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What is section 12(1) Who uses it?

Slide 26 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What is s12(1) of the Medicines Act? Exemption from licensing provisions of Medicines Act 1968 Cannot apply to any medicines within scope of European Directive 2001/83/EC (eg industrially produced medicines) Running a business, in which there is -face to face consultation; request for exercise of judgement -unlicensed herbal medicine prepared on lockable premises of occupier carrying out the business No current requirement for the practitioner carrying out s12(1) to have any competence in diagnosis, treatment or in preparation of medicines

Slide 27 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Some misunderstandings…. Does advising patient which herbal medicine to choose of itself bring the product within s12(1)? No – if a herbal medicine can legally be sold without a consultation, the fact that there is a consultation doesnt mean that s12(1) needs to exist for that activity to remain legal Are all herbal products prepared or supplied by CAM practitioners medicines? No - a range of herbal ingredients have non medicinal uses eg for nutritional, well being, health maintenance, cosmetic purposes, and in aromatherapy (see MHRA website Borderline Products for further information)

Slide 28 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Who uses s12(1)? Practitioners of herbal medicine within various traditions (eg western, traditional Chinese, Ayurveda) May be some usage elsewhere, eg in some regulated healthcare professions, in acupuncture, naturopathy, aromatherapy, homoeopathy, a few shop keepers in herbal shops, some multi disciplinary CAM practitioners, weekend course herbal practitioners….. Extent of usage of s12(1) outside conventional herbal practitioners very difficult to quantify....

Slide 29 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Examples of problems with quantifying s12(1) activity (i) Aromatherapy – MHRA would not generally regard typical essential oils for external use as medicinal – but -medicinal claims for an aromatherapy product would make product medicinal -supplying essential oil products for internal use would normally be regarded as medicinal

Slide 30 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Examples of problems with quantifying s12(1) activity (ii) MHRA field work suggests indeterminate practice has grown up in unregulated sector, eg: -clinic having a shop front where assistant dispenses remedies made up by a practitioner – is there a consultation carried out to professional standards? -outlets where herbal remedy made up at request of customer with the possibility of some form of consultation/advice on request Some activity seems to blur retail/practitioner activity

Slide 31 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Examples of problems with quantifying s12(1) activity (iii) Many herbal ingredients have more than one use Advice is in MHRAs guidance Note 8 A guide to what is a medicinal product -Guidance sheet on herbal ingredients; includes -List of herbal ingredients and their reported uses

Slide 32 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Which products are medicines? Any substance or combination of substances presented for treating or preventing disease in human beings Any substance or combination of substances which may be used in or administered to human beings either with a view to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis Definition in 2001/83/EC (as amended by 2004/27/EC ) Guidance about borderline products (including herbal products) on MHRA website:

Slide 33 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Proposals for Reform of s12(1)

Slide 34 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 MHRA proposed foundations for reform of s12(1) MHRA suggests that single most effective safeguard for public is that practitioners who use s12(1) (ie to run a business to identify individual needs through consultation and then make up unlicensed herbal medicine suitable to meet patients needs) should be: -identifiable in law -recognised as competent/expert in the practice of herbal medicine -professionally accountable

Slide 35 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Summary of MHRA proposals for s12(1) reforms (i) Use of s12(1) restricted to statutorily regulated healthcare professionals who are held professionally accountable Significant elements of regulation achieved via professional code(s); some elements in medicines legislation Transitional period giving s12(1) users opportunity to join register Face to face consultation requirement in legislation to remain; other aspects of consultation to be covered in codes of practice

Slide 36 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Summary of MHRA proposals for s12(1) reforms (ii) Efficacy – professional responsibility Quality of s12(1) products – safeguards mainly via code agreed with the profession Safety of s12(1) products – restriction on named potent ingredients via legislation and/or agreement with the profession – (review when DH proposals on statutory regulation further advanced) Herbal formulary of acceptable herbs to be developed by profession; to be reviewed by Herbal Medicines Advisory Committee (HMAC)

Slide 37 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Summary of MHRA proposals for s12(1) reforms (iii) Statutorily regulated healthcare professionals to be able to commission manufacture from a 3 rd party of an unlicensed herbal medicine to meet special needs: -registered herbal practitioners could be regarded as authorised health care professionals under Art 5.1 of Directive 2001/83/EC -implement via revised version of existing specials scheme Possibility of limited extension of s12(1) to certain non herbal ingredients used in traditional medicines

Slide 38 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Regulatory impact – the dilemma If anyone can use s12(1) Disincentive – why register if you can carry on practising anyway? Message to public is buyer beware? Jeopardise efforts to improve standards eg in TCM sector? Undermine programme to improve standards in OTC sector? If s12(1) limited to statutorily regulated, accountable professionals CAM practitioners would need to join statutory register if they wished to operate a business preparing herbal medicines to meet individual needs identified in consultation Impact on practitioners who make limited use of s12(1) provision? Unregistered practitioners restricted to supplying herbals that are not medicines, and to regulated herbal medicines

Slide 39 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Questions…… If you support s12(1) remaining open to all, how should the public be protected from unprofessional practitioners operating to low standards? If you believe that in future some but not all unregistered practitioners should be able to use s12(1) how would you distinguish in law which practitioners are competent? If s12(1) is restricted to statutorily regulated practitioners how much notice would be needed before change is introduced?

Slide 40 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 What next ….

Slide 41 Date: January 2007 Name: Richard Woodfield Title: Reforms of s12(1) of the Medicine Act 1968 © Crown copyright 2005 Next Steps …. Initially informal consultation until end March Views welcome! To: Take stock in light of: -comments raised -progress of work on statutory regulation of profession Updated proposals for formal consultation alongside DH consultation on the regulation of the profession